ValiRx plc (LON:VAL – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 0.31 and traded as low as GBX 0.19. ValiRx shares last traded at GBX 0.20, with a volume of 74,967,289 shares trading hands.
ValiRx Stock Down 2.6%
The company has a market cap of £1.41 million, a PE ratio of -0.20 and a beta of 0.59. The business has a 50-day simple moving average of GBX 0.28 and a 200-day simple moving average of GBX 0.31. The company has a quick ratio of 1.27, a current ratio of 9.66 and a debt-to-equity ratio of 0.19.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
